Neogenomics (NEO) Launches COVID-19 Testing, PT Raised to $39 as at Needham
Tweet Send to a Friend
Needham & Company analyst Stephen Unger raised the price target on Neogenomics (NASDAQ: NEO) to $39.00 (from $33.00) after the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
